RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 62 filers reported holding RECRO PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $11,120,000 | -36.8% | 1,010,000 | -46.9% | 0.38% | -44.4% |
Q4 2017 | $17,591,000 | +3.0% | 1,901,685 | 0.0% | 0.69% | -10.0% |
Q3 2017 | $17,077,000 | +27.7% | 1,901,685 | 0.0% | 0.77% | +7.9% |
Q2 2017 | $13,369,000 | -26.3% | 1,901,685 | -8.4% | 0.71% | +2.0% |
Q1 2017 | $18,136,000 | +8.4% | 2,075,000 | 0.0% | 0.70% | +1.6% |
Q4 2016 | $16,725,000 | – | 2,075,000 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |